Holen Sie sich die Stockscreener-App
43.00
5.49%
-2.50
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - Bluefield Daily Telegraph
Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny - TechStock²
Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts - Insider Monkey
Why Soleno Therapeutics Inc. stock is popular among millennialsWeekly Investment Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Assessing Soleno Therapeutics (SLNO) Valuation After JCEM VYKAT XR Data And FDA Approval - Yahoo Finance
Macro Review: Can Soleno Therapeutics Inc. stock hit record highs againJuly 2025 Short Interest & Expert Curated Trade Setups - ulpravda.ru
Can Soleno Therapeutics Inc. stock hit record highs again2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the ... - Bluefield Daily Telegraph
Star Tribune - FinancialContent
12 Stocks that Will Bounce Back According to Wall Street Analysts - Insider Monkey
Will Soleno Therapeutics Inc. stock deliver strong dividend growthQuarterly Profit Review & Expert Curated Trade Setup Alerts - ulpravda.ru
What technical signals suggest for Soleno Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru
Does Soleno Therapeutics Inc. stock trade at a discount to peersWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Soleno Therapeutics announces entry into $100M accelerated share repurchase agreement - MSN
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Is Soleno Therapeutics Inc. stock supported by strong fundamentalsEconomic Data Impact & Market-Leading Growth Rates - ulpravda.ru
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - MSN
Soleno’s PWS treatment study results published in endocrinology journal By Investing.com - Investing.com Nigeria
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - Chartmill
Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)? - Insider Monkey
A Look At Soleno Therapeutics (SLNO) Valuation After Pivotal VYKAT XR Study Publication And FDA Approval - Sahm
Soleno’s PWS treatment study results published in endocrinology journal - Investing.com
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling The 140% Upside Potential - DirectorsTalk Interviews
Soleno Therapeutics Announces Publication of Positive Study Results for VYKAT XR in Journal of Clinical Endocrinology and Metabolism - Quiver Quantitative
New PWS hunger drug shows symptoms worsen off treatment in key study - Stock Titan
Allspring Global Investments Holdings LLC Buys 201,983 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Cut by Voya Investment Management LLC - MarketBeat
SLNO News Today | Why did Soleno Therapeutics stock go up today? - MarketBeat
Understanding Momentum Shifts in (SLNO) - Stock Traders Daily
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Risk Hedge: Why analysts recommend Soleno Therapeutics Inc 6XC stock2025 Trading Volume Trends & Community Consensus Trade Alerts - moha.gov.vn
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. $SLNO Stake Lessened by Harbor Capital Advisors Inc. - MarketBeat
Market Sentiment Around Loss-Making Soleno Therapeutics, Inc. (NASDAQ:SLNO) - 富途牛牛
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics Earnings Notes - Trefis
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Soleno Therapeutics Inc. stock affected by interest rate hikesMarket Sentiment Report & Free High Margin Investment Plays - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-24 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛
Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):